Company

Translation-X

Translation-X researches RNA-based treatments for autism spectrum disorders.

About

Translation-X researches therapeutic approaches for autism spectrum disorders, with a focus on precision medicine and RNA-based treatments. Founded in 2022 by Özgür Genç, the company is based in Basel, Switzerland. In October 2024, it raised CHF 0.15 million in venture funding from Venture Kick.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in